These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16603757)

  • 1. Hepatitis C treatment eligibility and outcomes among patients with psychiatric illness.
    Rifai MA; Moles JK; Short DD
    Psychiatr Serv; 2006 Apr; 57(4):570-2. PubMed ID: 16603757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
    Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.
    Sylvestre DL; Loftis JM; Hauser P; Genser S; Cesari H; Borek N; Kresina TF; Seeff L; Francis H
    J Urban Health; 2004 Dec; 81(4):719-34. PubMed ID: 15466851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating hepatitis C virus infection in active substance users.
    Sylvestre DL
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S321-4. PubMed ID: 15768341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel program for treating patients with trimorbidity: hepatitis C, serious mental illness, and active substance use.
    Sockalingam S; Blank D; Banga CA; Mason K; Dodd Z; Powis J
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1377-84. PubMed ID: 23680911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans.
    Dollarhide AW; Loh C; Leckband SG; Endow-Eyer R; Robinson S; Meyer JM
    J Clin Gastroenterol; 2007 Mar; 41(3):322-8. PubMed ID: 17426475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C among patients with mental illness in Brazil: an analysis of associated factors.
    Carmo RA; Campos LN; Melo AP; Guimarães MD
    Gen Hosp Psychiatry; 2013; 35(2):129-33. PubMed ID: 23260338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
    Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
    J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness.
    Van Thiel DH; Friedlander L; Molloy PJ; Fagiuoli S; Kania RJ; Caraceni P
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):165-8. PubMed ID: 7712309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: need for team care.
    Fleming CA; Tumilty S; Murray JE; Nunes D
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S349-54. PubMed ID: 15768347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.
    Litwin AH; Soloway I; Gourevitch MN
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S339-45. PubMed ID: 15768345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of disease in U.S. veteran patients with hepatitis C.
    Nguyen HA; Miller AI; Dieperink E; Willenbring ML; Tetrick LL; Durfee JM; Ewing SL; Ho SB
    Am J Gastroenterol; 2002 Jul; 97(7):1813-20. PubMed ID: 12135041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders.
    Chainuvati S; Khalid SK; Kancir S; Shea M; Edwards J; Sernyak M; Wongcharatrawee S; Garcia-Tsao G
    J Viral Hepat; 2006 Apr; 13(4):235-41. PubMed ID: 16611189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of mental health problems prior to and during treatment of hepatitis C virus infection in patients with drug addiction.
    Schaefer M; Sarkar R; Diez-Quevedo C
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S111-7. PubMed ID: 23884058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients.
    Charlebois A; Lee L; Cooper E; Mason K; Powis J
    J Viral Hepat; 2012 Dec; 19(12):836-42. PubMed ID: 23121361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
    Braitstein P; Li K; Kerr T; Montaner JS; Hogg RS; Wood E
    AIDS Care; 2006 Oct; 18(7):690-3. PubMed ID: 16971276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment.
    Fleming CA; Craven DE; Thornton D; Tumilty S; Nunes D
    Clin Infect Dis; 2003 Jan; 36(1):97-100. PubMed ID: 12491208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric barriers to readiness for treatment for hepatitis C Virus (HCV) infection among injection drug users: clinical experience of an addiction psychiatrist in the HIV-HCV coinfection clinic of a public health hospital.
    Scheft H; Fontenette DC
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S292-6. PubMed ID: 15768337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How many patients with chronic viral hepatitis qualify for interferon therapy? Prospective analysis of university ambulatory care].
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Med Klin (Munich); 1993 Sep; 88(9):511-5, 562. PubMed ID: 8232088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bipolar patients can safely and successfully receive interferon-based hepatitis C antiviral treatment.
    Kelly EM; Corace K; Emery J; Cooper CL
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):811-6. PubMed ID: 22495398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.